Consensus guidelines for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease in adult Asian Indians with type 2 diabetes
Diabetes & Metabolic Syndrome: Clinical Research & Reviews · 2025
DOI: 10.1016/j.dsx.2025.103209 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2025. Verfasst von Anoop Misra und 9 weiteren Autor:innen. Beteiligte Einrichtung: Fortis CDOC Center of Excellence for Diabetes, Metabolic Diseases and Endocrinology, New Delhi, India; National Diabetes Obesity and Cholesterol Foun…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Consensus, Practice Guidelines as Topic, Fatty Liver. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 297 Literaturangaben. Gefördert von: AstraZeneca, Sun Pharma, Universitatea Ștefan cel Mare din Suceava.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a critical health concern among Asian Indians with type 2 diabetes (T2D), characterized by particularly high prevalence and risk of progression. The need for specific guidelines addressing this dual epidemic is vital, given the adverse metabolic characteristics of Asian Indians. METHODS: A comprehensive literature review was conducted across major databases (PubMed, Embase, Cochrane Library, and Google Scholar) up to December 2024. For topics lacking robust evidence, a modified Delphi survey was conducted among endocrinologists, diabetologists, and gastroenterologists across India. Consensus statements were developed through a systematic process involving a core task force of nine experts. RESULTS: The consensus provides evidence-based recommendations for the screening, diagnosis, and management of MASLD in individuals with T2D. Key findings include mandatory screening for all individuals with T2D, with particular attention to those exhibiting high-risk features such as metabolic syndrome and obesity. Non-invasive tools, such as FIB-4 or vibration-controlled transient elastography, are recommended for fibrosis assessment. Management strategies encompass lifestyle modifications, pharmacological interventions, and surgical options when appropriate. The consensus also addresses specific considerations for hepatocellular carcinoma surveillance in patients with advanced fibrosis and compensated cirrhosis. CONCLUSIONS: These consensus guidelines offer the first tailored, evidence-based recommendations for the management of MASLD in Asian Indians with T2D, addressing the unique metabolic and clinical characteristics of this population. The guidelines emphasize proactive screening, regular monitoring, and early intervention, along with a comprehensive, multi-modal treatment approach to optimize outcomes in this high-risk group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Fortis CDOC Center of Excellence for Diabetes, Metabolic Diseases and Endocrinology, New Delhi, India; National Diabetes Obesity and Cholesterol Foundation (N-DOC), New Delhi, India; Diabetes Foundation India, New Delhi…
- Gastroenterology & Hepatology,Sir Ganga Ram Hospital, Rajinder Nagar New Delhi, India.
- Division of Endocrinology and Diabetes, Medanta, The Medicity, Gurugram, 122001, Haryana, India.
- Fortis CDOC Center of Excellence for Diabetes, Metabolic Diseases and Endocrinology, New Delhi, India; National Diabetes Obesity and Cholesterol Foundation (N-DOC), New Delhi, India.
- National Diabetes Obesity and Cholesterol Foundation (N-DOC), New Delhi, India; Diabetes Foundation India, New Delhi, India.
- Hepatology, Medanta the Medicity, Gurugram, 122001, Haryana, India.
Förderung
- AstraZeneca
- Sun Pharma
- Universitatea Ștefan cel Mare din Suceava
Zitieren
APA
Misra, A., Kumar, A., Kuchay, M. S., Ghosh, A., Gulati, S., Choudhary, N. S., Dutta, D., Sharma, P., Vikram, N. K., & Delphi Committee (2025). Consensus guidelines for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease in adult Asian Indians with type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. https://doi.org/10.1016/j.dsx.2025.103209
Vancouver
Misra A, Kumar A, Kuchay MS, Ghosh A, Gulati S, Choudhary NS, et al. Consensus guidelines for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease in adult Asian Indians with type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2025. doi:10.1016/j.dsx.2025.103209
BibTeX
@article{Misra2025,
author = {Misra, Anoop and Kumar, Ashish and Kuchay, Mohammad Shafi and Ghosh, Amerta and Gulati, Seema and Choudhary, Narendra Singh and Dutta, Deep and Sharma, Praveen and Vikram, Naval K and Delphi Committee, Delphi Committee},
title = {Consensus guidelines for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease in adult Asian Indians with type 2 diabetes},
journal = {Diabetes & Metabolic Syndrome: Clinical Research & Reviews},
year = {2025},
doi = {10.1016/j.dsx.2025.103209}
}
EUVIMED